Triple T, a new minimally invasive therapy, could replace adrenal surgery for treating primary aldosteronism, a hidden cause ...

Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

There’s nothing better than a proper cooked breakfast. Here’s how to get the day off to a heart-healthy start (and save over ...

Lakes and rivers that used to be trusted sources of potable water in the country now pose danger to women's fertility ...

Getting a stain on your favorite item of clothing can cause immediate panic and you might frantically try anything to treat ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Pope Francis was hospitalized Friday to treat a weeklong bout of bronchitis and undergo diagnostic tests, the Vatican said, ...